跳至主要内容
临床试验/EUCTR2014-002970-36-NL
EUCTR2014-002970-36-NL进行中(未招募)1 期

Human intestinal ischemia and reperfusion - Human intestinal IR

Maastricht University Medical Center0 个研究点开始时间: 2016年1月13日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Adult patients (18 years of age and older) undergoing major upper abdominal surgery
  • oWhipple-procedure or pylorus preserving pancreatico duodenectomy (PPPD)
  • oIleo-Jejunal bypass surgery
  • oRoux-en-Y gastric bypass
  • oTotal gastrectomy
  • oHepatico jejunostomy
  • oPancreaticojejunostomy (Frey’s procedure)
  • Patients who have given an informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 21
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 21

排除标准

  • <18 years of age or older but no proper understanding of the research proposal
  • Inflammatory bowel disease
  • Celiac disease
  • Acute major abdominal procedures
  • Patients who have refused informed consent
  • For the population who will receive tranexamic acid additional exclusion criteria have been formulated:
  • Active or history of thrombo-embolic disorders such as deep venous thrombosis, pulmonary embolism or cerebral embolism
  • History of blood coagulation disorder (hypercoagulation state)
  • Subarachnoid hemorrhage
  • Disseminated intravascular coagulation (DIS)
  • Severe renal insufficiency: i.e. serum kreatinine >150 µmol/L
  • History of convulsions
  • Known hypersensitivity of allergy for tranexamic acid
  • Simultaneous use of thrombolytics (e.g. alteplase, streptokinase)
  • Simultaneous use of hormonal anticonceptives or other substances that induce hemostasis.
  • For the population who will receive doxycycline additional exclusion criteria have been formulated:
  • Known hypersensitivity of allergy for tetracyclines.
  • Severe liver function disorder i.e. ASAT or ALAT or AF or ?-GT >150 U/L whether or not combined with severe renal insufficiency: i.e. serum kreatinine >150 µmol/L.
  • Severe renal insufficiency: i.e. serum kreatinine >150 µmol/L.
  • Myasthenia gravis
  • Simultaneous usage (or just before or after administration of doxycycline) of oral retinoids or substances containing metalions (such as antagel or ironpreparations)
  • Simultaneous use of methoxyflurane (anesthetic) or oral contraceptives
  • Bodyweight beneath 50 kg
  • History of blood coagulation disorder (inert hypocoagulation state)
  • Pregnancy or lactating

研究者

相似试验